GLIS2 and acute myeloid leukemia: Thus, the diagnosis of AMKL with inv(16)(p13q24)/CBFA2T3::GLIS2 was established, and the patient received AML-MRD-2018 protocol induction therapy, consisting of cytarabine, etoposide and idarubicin [31,32].